Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The -Cu denotes that bound copper
Semaglutide and tirzepatide are FDA-approved with extensive clinical trial data showing average 15-20% body weight loss, improvements in cardiovascular health markers, reduction in obesity-related disease risk, and excellent safety profile with proper medical supervision
This maintains receptor sensitivity, allows assessment of results, and reduces risk of side effects from prolonged GH elevation
Sakanashi M et al
If you have tried one type of compounded semaglutide and experienced side effects or suboptimal results, having nine-plus formulations available through a single provider is valuable
US$ 20.20
US$ 20.87
US$ 23.96
US$ 27.28
